Exelixis Inc Revenue per Employee (EXEL), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket
 


Exelixis Inc   (NASDAQ: EXEL)
 

Exelixis Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 9.97% in the first quarter 2026, year on year to cumulative value of $2,375 million, Exelixis Inc 's revenue per employee grew on a trailing twelve months basis to $ 2,071,047, this marks a new company high.
Within the Healthcare sector Employees of 16 other companies have achieved higher revenue per employee. While Exelixis Inc 's total ranking has deteriorated compared to the previous quarter from 111 to 282. Exelixis Inc has 1,147 employees.


What is Sales per Employee Ratio?







EXEL Revenue per Employee (Apr 03 2026)
I. Quarter
(Jan 02 2026)
IV. Quarter
(Oct 03 2025)
III. Quarter
(Jul 04 2025)
II. Quarter
(Apr 04 2025)
I. Quarter
Y / Y Revenue Change 9.97 % 5.63 % 10.79 % -10.82 % 30.62 %
Sales per Employee (TTM) $ 2,071,047 2,022,778 1,994,959 1,944,207 2,004,291
EXEL's Total Ranking # 282 # 111 # 203 # 43 # 232
Seq. Revenue Change 2.03 % 0.15 % 5.19 % 2.31 % -2 %


Revenue per Employee Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 3
Healthcare Sector # 17
Overall Market # 282

Revenue per Employee Statistics
High Average Low
$ 2,071,047 $ 896,079 $ 15,376
(Apr 03 2026)   (June 30. 2014)



Financial Statements
Exelixis Inc 's Revenue MRQ $ 611 Millions Visit EXEL's Income Statement
Exelixis Inc 's Revenues TTM $ 2,375 Millions Visit EXEL's aggregate revenue growth
What are EXEL's Sales? Visit EXEL's Sales by Segment




Other Ratios
Exelixis Inc 's Income per Employee
Employees in Biotechnology & Pharmaceuticals
Biotechnology & Pharmaceuticals Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
EXEL's Revenue per Employee versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for EXEL's Competitors
Revenue per Employee for EXEL's Suppliers
Revenue per Employee for EXEL's Customers

You may also want to know
EXEL's Sales Growth Rates EXEL's Pe Price to earnings ratio EXEL's Receivables Turnover Ratio EXEL's Stock Quote
EXEL's Net Income Growth Rates EXEL's Ps Price to Sales ratio EXEL's Sales per Employee EXEL's Asset Turnover Ratio
EXEL's Net Margin EXEL's Pb Price to Book ratio EXEL's Financial Strength Ratios EXEL's Dividend Payout Ratio
Date modified: 2026-09-08T15:11:40+00:00




Companies with similar Revenue per Employee for 12 months ending Apr 03 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Apr 03 2026Number of Employees Apr 03 2026
Ironwood Pharmaceuticals inc   3,615,140.00 $ 361.514  Million 100 
Halozyme Therapeutics Inc   3,566,094.56 $ 1,508.458  Million 423 
Aytu Biopharma Inc  3,478,937.50 $ 55.663  Million 16 
Xoma Royalty Corporation  3,468,214.29 $ 48.555  Million 14 
Illumina Inc   3,432,031.25 $ 4,393.000  Million 1,280 
Therapeuticsmd Inc   3,353,000.00 $ 3.353  Million
Nuvation Bio Inc   3,305,139.53 $ 142.121  Million 43 
Catalyst Pharmaceuticals Inc   3,279,989.01 $ 596.958  Million 182 
Harmony Biosciences Holdings inc   3,069,102.39 $ 899.247  Million 293 
Amgen Inc   2,863,076.92 $ 37,220.000  Million 13,000 
Sarepta Therapeutics Inc   2,615,789.22 $ 2,184.184  Million 835 
Innoviva Inc   2,479,150.94 $ 394.185  Million 159 
Spero Therapeutics Inc   2,447,440.00 $ 61.186  Million 25 
Aurinia Pharmaceuticals Inc   2,330,429.69 $ 298.295  Million 128 
United Therapeutics Corporation  2,264,142.86 $ 3,169.800  Million 1,400 
Elite Pharmaceuticals Inc   2,261,542.74 $ 147.000  Million 65 
Anaptysbio Inc   2,234,500.00 $ 232.388  Million 104 
Exelixis Inc   2,071,047.08 $ 2,375.491  Million 1,147 
Kiniksa Pharmaceuticals International Plc  2,060,232.24 $ 754.045  Million 366 
Cormedix Inc   2,040,572.14 $ 389.749  Million 191 
Biocryst Pharmaceuticals Inc   2,036,128.74 $ 885.716  Million 435 
Eton Pharmaceuticals Inc   1,968,500.00 $ 86.614  Million 44 
Assertio Holdings inc   1,927,509.43 $ 102.158  Million 53 
Siga Technologies Inc  1,913,809.53 $ 93.777  Million 49 
Prestige Consumer Healthcare Inc   1,909,785.96 $ 1,088.578  Million 570 
Zevra Therapeutics Inc   1,886,442.62 $ 115.073  Million 61 
Incyte Corporation  1,885,028.13 $ 5,361.020  Million 2,844 
Privia Health Group Inc   1,832,456.77 $ 2,246.592  Million 1,226 
Tg Therapeutics Inc   1,755,260.65 $ 700.349  Million 399 
Gilead Sciences Inc   1,749,176.47 $ 29,736.000  Million 17,000 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.